Zhaolei Jiang1, Ye Zhao2, Wei-Chung Tsai3, Yuan Yuan1, Kroekkiat Chinda4, Jian Tan5, Patrick Onkka5, Changyu Shen6, Lan S Chen7, Michael C Fishbein8, Shien-Fong Lin9, Peng-Sheng Chen5, Thomas H Everett10. 1. Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana; Department of Cardiothoracic Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. 2. Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana; Department of Cardiac Surgery, the First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China. 3. Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana; Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. 4. Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana; Department of Physiology, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand. 5. Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana. 6. Richard and Susan Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. 7. Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana. 8. Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California. 9. Institute of Biomedical Engineering, National Chiao-Tung University, Hsin-Chu, Taiwan. 10. Krannert Institute of Cardiology and Division of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana. Electronic address: theveret@iu.edu.
Abstract
OBJECTIVES: This study was designed to test the hypothesis that low-level vagal nerve stimulation (VNS) reduces the ventricular rate (VR) during atrial fibrillation (AF) through the activation of the inferior vena cava (IVC)-inferior atrial ganglionated plexus nerve activity (IAGPNA). BACKGROUND: Increased IVC-IAGPNA can suppress atrioventricular node conduction and slow VR in canine models of AF. METHODS: Persistent AF was induced in 6 dogs and the IVC-IAGPNA, right vagal nerve activity, left vagal nerve activity, and an electrocardiogram were recorded. After persistent AF was documented, VNS was programed to 14 s "on" and 1.1 min "off." After 1 week, the VNS was reprogramed to 3 min off and stimulation continued for another week. Neural remodeling of the stellate ganglion (SG) was assessed with tyrosine hydroxylase staining and terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick-end labeling staining. RESULTS: Average IVC-IAGPNA was increased during both VNS 1.1 min off (8.20 ± 2.25 μV [95% confidence interval (CI): 6.33 to 9.53 μV]; p = 0.002) and 3 min off (7.96 ± 2.03 μV [95% CI: 6.30 to 9.27 μV]; p = 0.001) versus baseline (7.14 ± 2.20 μV [95% CI: 5.35 to 8.52 μV]). VR was reduced during both VNS 1.1 min off (123.29 ± 6.29 beats/min [95% CI: 116.69 to 129.89 beats/min]; p = 0.001) and 3 min off (120.01 ± 4.93 beats/min [95% CI: 114.84 to 125.18 beats/min]; p = 0.001) compared to baseline (142.04 ± 7.93 bpm [95% CI: 133.72 to 150.37]). Abnormal regions were observed in the left SG, but not in the right SG. Terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick-end labeling-positive neurons were found in 22.2 ± 17.2% [95% CI: 0.9% to 43.5%] of left SG cells and 12.8 ± 8.4% [95% CI: 2.4% to 23.2%] of right SG cells. CONCLUSIONS: Chronic low-level VNS increases IVC-IAGPNA and damages bilateral stellate ganglia. Both mechanisms could contribute to the underlying mechanism of VR control during AF.
OBJECTIVES: This study was designed to test the hypothesis that low-level vagal nerve stimulation (VNS) reduces the ventricular rate (VR) during atrial fibrillation (AF) through the activation of the inferior vena cava (IVC)-inferior atrial ganglionated plexus nerve activity (IAGPNA). BACKGROUND: Increased IVC-IAGPNA can suppress atrioventricular node conduction and slow VR in canine models of AF. METHODS: Persistent AF was induced in 6 dogs and the IVC-IAGPNA, right vagal nerve activity, left vagal nerve activity, and an electrocardiogram were recorded. After persistent AF was documented, VNS was programed to 14 s "on" and 1.1 min "off." After 1 week, the VNS was reprogramed to 3 min off and stimulation continued for another week. Neural remodeling of the stellate ganglion (SG) was assessed with tyrosine hydroxylase staining and terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick-end labeling staining. RESULTS: Average IVC-IAGPNA was increased during both VNS 1.1 min off (8.20 ± 2.25 μV [95% confidence interval (CI): 6.33 to 9.53 μV]; p = 0.002) and 3 min off (7.96 ± 2.03 μV [95% CI: 6.30 to 9.27 μV]; p = 0.001) versus baseline (7.14 ± 2.20 μV [95% CI: 5.35 to 8.52 μV]). VR was reduced during both VNS 1.1 min off (123.29 ± 6.29 beats/min [95% CI: 116.69 to 129.89 beats/min]; p = 0.001) and 3 min off (120.01 ± 4.93 beats/min [95% CI: 114.84 to 125.18 beats/min]; p = 0.001) compared to baseline (142.04 ± 7.93 bpm [95% CI: 133.72 to 150.37]). Abnormal regions were observed in the left SG, but not in the right SG. Terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick-end labeling-positive neurons were found in 22.2 ± 17.2% [95% CI: 0.9% to 43.5%] of left SG cells and 12.8 ± 8.4% [95% CI: 2.4% to 23.2%] of right SG cells. CONCLUSIONS: Chronic low-level VNS increases IVC-IAGPNA and damages bilateral stellate ganglia. Both mechanisms could contribute to the underlying mechanism of VR control during AF.
Authors: Atsuko Seki; Hunter R Green; Thomas D Lee; LongSheng Hong; Jian Tan; Harry V Vinters; Peng-Sheng Chen; Michael C Fishbein Journal: Heart Rhythm Date: 2014-04-24 Impact factor: 6.343
Authors: Lilian Kornet; Arne van Hunnik; Koen Michels; Sander Verheule; Alberto Della Scala; Teena West; Roger Kessels; Richard Cornelussen Journal: J Interv Card Electrophysiol Date: 2011-10-04 Impact factor: 1.900
Authors: Mark J Shen; Tetsuji Shinohara; Hyung-Wook Park; Kyle Frick; Daniel S Ice; Eue-Keun Choi; Seongwook Han; Mitsunori Maruyama; Rahul Sharma; Changyu Shen; Michael C Fishbein; Lan S Chen; John C Lopshire; Douglas P Zipes; Shien-Fong Lin; Peng-Sheng Chen Journal: Circulation Date: 2011-05-09 Impact factor: 29.690
Authors: Patrick Onkka; Waddah Maskoun; Kyoung-Suk Rhee; Jessica Hellyer; Jheel Patel; Jian Tan; Lan S Chen; Harry V Vinters; Michael C Fishbein; Peng-Sheng Chen Journal: Heart Rhythm Date: 2012-12-11 Impact factor: 6.343
Authors: Eric A Robinson; Kyoung-Suk Rhee; Anisiia Doytchinova; Mohineesh Kumar; Richard Shelton; Zhaolei Jiang; Nicholas J Kamp; David Adams; David Wagner; Changyu Shen; Lan S Chen; Thomas H Everett; Michael C Fishbein; Shien-Fong Lin; Peng-Sheng Chen Journal: J Cardiovasc Electrophysiol Date: 2014-09-04
Authors: Kroekkiat Chinda; Wei-Chung Tsai; Yi-Hsin Chan; Andrew Y-T Lin; Jheel Patel; Ye Zhao; Alex Y Tan; Mark J Shen; Hongbo Lin; Changyu Shen; Nipon Chattipakorn; Michael Rubart-von der Lohe; Lan S Chen; Michael C Fishbein; Shien-Fong Lin; Zhenhui Chen; Peng-Sheng Chen Journal: Heart Rhythm Date: 2015-12-01 Impact factor: 6.343
Authors: Peter Hanna; Eric Buch; Stavros Stavrakis; Christian Meyer; John D Tompkins; Jeffrey L Ardell; Kalyanam Shivkumar Journal: Cardiovasc Res Date: 2021-06-16 Impact factor: 10.787